no key · no human

BiopharmaWatch API, RSS and sitemap

Every article BiopharmaWatch publishes, as JSON, through an open API with no key and no signup. 843 of their articles are indexed right now, refreshed hourly.

English#3,303 by volume

Four ways to pull biopharmawatch.com

All four are ours, all four are live, and none of them needs a key.

JSON Search this publisher

Every article we hold from biopharmawatch.com, newest first. Add q= to search inside.

curl -s "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&size=20"open it →

RSS Subscribe in any reader

The same articles as an RSS 2.0 feed. Works in Feedly, Inoreader, Thunderbird — anywhere.

curl -s "https://freenewsapi.ai/v1/rss?host=www.biopharmawatch.com&size=50"open it →

JSON Feed For apps

JSON Feed 1.1, the same content in a format apps parse natively.

curl -s "https://freenewsapi.ai/v1/feed.json?host=www.biopharmawatch.com&size=50"open it →

Trimmed For agents

Only the fields an agent needs — title, url, date, language — so the response stays small.

curl -s "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&size=20&fields=title,url,published_at,lang"open it →

What this outlet covers, by share of its recent output:

health 39%crypto 13%business 11%society 11%

Call the API

A live request. Paste it into a terminal and BiopharmaWatch headlines come back as JSON.

bash
curl "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&size=5"
843
articles indexed
843
in the last 30 days
79
median per day
1
languages
13 min
median crawl lag
25.08 → 07.09
archive depth

Publishing volume

Articles per day over the last 13 days. The busiest hour is 12:00 UTC — that is when the newsroom pushes its main batch.

2026-08-25: 46 articles2026-08-26: 66 articles2026-08-27: 104 articles2026-08-28: 79 articles2026-08-29: 6 articles2026-08-30: 4 articles2026-08-31: 87 articles2026-09-01: 143 articles2026-09-02: 116 articles2026-09-03: 106 articles2026-09-04: 79 articles2026-09-06: 2 articles2026-09-07: 5 articles08-2508-2708-2908-3109-0209-0409-07
bash
curl "https://freenewsapi.ai/v1/stats?host=www.biopharmawatch.com&top=10"

Publishing rhythm

When BiopharmaWatch actually publishes, by hour of day (UTC) and by day of week — measured from 843 timestamps, not from a schedule they advertise.

00: 200001: 20102: 50203: 20304: 70405: 50506: 110607: 80708: 80809: 40910: 431011: 1351112: 2321213: 811314: 161415: 161516: 91617: 61718: 91819: 121920: 1592021: 242122: 222223: 723
Mon: 92MonTue: 189TueWed: 182WedThu: 210ThuFri: 158FriSat: 6SatSun: 6Sun

Sections

Sections come from the publisher's own markup, present on 21% of their articles.

SectionArticles
health181

Languages

CodeLanguageArticlesShare
enEnglish843100.0%

Latest articles

The 18 most recent BiopharmaWatch articles in the index — the same rows the API returns, rendered for humans.

Genflow Biosciences PLC Announces Appointment of Investor Relations Adviser
2026-09-07 02:00 UTC
Genflow Biosciences appoints ON365 as its investor relations adviser to enhance engagement as it advances its SIRT6 gene therapy platform.
Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension
2026-09-06 05:00 UTC
Roivant will present Phase 2 PHocus study results for mosliciguat at ERS Congress 2026 on September 8, 2026.
Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
2026-09-04 22:32 UTC
Stryker will participate in the 2026 Wells Fargo Healthcare Conference on Sept 8, featuring a fireside chat with key executives.
Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (
2026-09-04 22:10 UTC
Guardant Health's Guardant360® CDx receives FDA approval for advanced breast cancer, aiding in patient identification for ETCAMAH™ treatment.
Defence Therapeutics Provides Updates on Sharing Agreement
2026-09-04 22:00 UTC
Defence Therapeutics updates on its Sharing Agreement, confirming $9.6M raised and cash settlements.
Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-04 21:05 UTC
Actinium Pharmaceuticals will present at the H.C. Wainwright Conference on September 14, 2026, focusing on targeted radiotherapies.
Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and
2026-09-04 20:41 UTC
Novartis announced that pelacarsen Phase 3 trial did not meet its primary endpoint, raising concerns about its efficacy.
Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established
2026-09-04 20:30 UTC
Novartis reveals Lp(a)HORIZON Phase III trial results for pelacarsen, which did not meet its primary endpoint despite lowering Lp(a) levels.
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
2026-09-04 20:05 UTC
Rapid Micro Biosystems (RPID) to engage investors at multiple conferences in September 2026.
NOMAD POWER SOLUTIONS ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS
2026-09-04 20:05 UTC
NOMAD Power Solutions adjourns Special Meeting to finalize Nasdaq listing. Meeting reconvenes on October 2, 2026.
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-09-04 20:01 UTC
Apnimed granted stock options to new employees under Nasdaq Rule 5635. The company advances AD109 for obstructive sleep apnea.
Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference
2026-09-04 20:01 UTC
Kiniksa Pharmaceuticals will present at the Wells Fargo Healthcare Conference on September 9, 2026, with a live webcast available.
Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study
2026-09-04 20:00 UTC
Inhibrx will host a webcast on September 8 to present results from the Phase 2 study of INBRX-106 for HNSCC.
Medtronic executives to speak at upcoming investor conferences
2026-09-04 16:34 UTC
Medtronic will participate in investor conferences on Sept 8 and 15, 2026, featuring top executives.

Harvest it all

Page through the archive by date. from and to accept YYYY-MM-DD or relative values such as now-7d.

bash
curl "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&from=now-7d&size=100"

To poll for new material, keep the timestamp of the newest article you saw and ask only for what came after it:

bash
curl "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&from=now-1h&sort=date_asc"

Article bodies come with full_text=true. No key, no quota tier, no header — see the search endpoint for every parameter.

Metadata quality

How well BiopharmaWatch marks up its own pages — useful if you are deciding whether to parse them yourself.

0%
dates from JSON-LD
0%
articles with a byline
21%
articles with sections
average page weight

Crawl lag — the delay between publication and the article reaching this index — is 13 min at the median, 3082 minutes at the 90th percentile.

Similar publishers

Comparable outlets in the same language. Those without a page here yet link straight to their slice of the API.

FAQ

Does BiopharmaWatch have an official API?

Not a public one. This endpoint is the practical alternative: their articles as structured JSON, with title, lead, publication time, section, byline and a link back to the original.

How do I get their RSS feed?

Most publishers expose one at /rss or /feed, but feeds carry only the last few dozen items and drop them within hours. This index keeps 843 of their articles and lets you filter by date, language and section.

How many articles does BiopharmaWatch publish per day?

79 on a median day, measured across 13 days.

Can I use this commercially?

The API is free and unauthenticated. What you may do with the content is between you and the publisher: we return metadata, a lead paragraph and a link, not a licence.